Introduction {#sec1}
============

Persistent hyperplastic primary vitreous (PHPV), a potentially blinding childhood disease, is one of the most common congenital malformation syndromes of the eye. PHPV pathology usually occurs unilaterally, but a rare bilateral condition has also been described ([@ref12]; [@ref52]; [@ref49]). Although intraocular lens implantation and surgical intervention have been used to prevent PHPV-induced progressive glaucoma and pupillary blockage ([@ref12]; [@ref43]; [@ref1]; [@ref20]), the outcome of PHPV is barely satisfactory. Furthermore, the cellular and molecular mechanisms responsible for the development of PHPV remain largely unclear.

During eye development a transient capillary network hyaloid vascular system (HVS) forms around the fourth to seventh week of human fetal life ([@ref55]; [@ref13]), providing nutrition to the developing lens, vitreous, and retina before the intraretinal vasculature is formed ([@ref12]; [@ref21]). During later stages of mammalian eye development, the HVS undergoes dramatic involution (in humans, by embryonic week 20; in mouse, by E13.5) ([@ref21]; [@ref13]). Failed HVS regression results in congenital malformation of human eye disease known as PHPV ([@ref43]; [@ref54]). Previous studies with ochratoxin A have demonstrated abnormal migration of excessive mesenchymal cells in PHPV tissues in both eyes, containing melanocytes derived from the neural crest ([@ref3]; [@ref35]). Moreover, fate maps developed in quail chick chimeras have demonstrated that periocular mesenchyme contains initial cell linages from both the neural crest and the mesoderm ([@ref23]; [@ref30]; [@ref29]). Subsequently, abnormal development of neural crest cells (NCCs) during embryonic fissure closure (4--7 weeks of gestation) can result in Peters' anomaly, PHPV, and other ocular malformations ([@ref35]).

Multiple signaling pathways have been reported to be involved in PHPV formation, which include proto-oncogene *ski* ([@ref37]), tumor suppressor gene *Arf* ([@ref38]; [@ref34]; [@ref61]; [@ref10]), *p53* ([@ref47]), *Frizzled-5* ([@ref68]), *ATOH7* ([@ref44]), *ang-2* ([@ref14]), *Bax* and *Bak* ([@ref16]), *FZD4* ([@ref54]; [@ref27]), *LRP5* ([@ref54]; [@ref27]), *ephrin-B2* ([@ref51]), and *ephrin-A5* ([@ref56]). Despite the fact that NCC input contributes to the detrimental, redundant retrolental mass via an unclosed ocular fissure, the relationship between fissure closure and PHPV is yet to be defined.

Neogenin is initially identified as a DCC (deleted in colon cancer) family receptor, which binds to axon guidance cues of netrins and RGMs, implicated in axon pathfinding ([@ref39]; [@ref65]; [@ref8]; [@ref67]). Neogenin also acts as a co-receptor for bone morphogenetic proteins (BMPs), involved in BMP regulated iron homeostasis, astrogliogenesis, and endochondrial bone formation ([@ref31]; [@ref69]; [@ref19]). Recently, neogenin is found to be a key regulator of adult hippocampal neurogenesis ([@ref58]). Neogenin is highly expressed in embryonic retina, exhibiting a temporal--nasal expression pattern ([@ref46]; [@ref53]), where it is implicated in regulating retinal axonal pathfinding. However, the exact role of neogenin in retina/eye development remains largely unclear.

Here we provide evidence that loss of neogenin contributes to the formation of PHPV. Neogenin is highly expressed in NCCs in developing embryos. Conditionally knocking out (cKO) neogenin in NCCs (by *Wnt1*-Cre) resulted in PHPV-like phenotype. Further characterizing phenotypes in neogenin cKO embryos and in NCC cultures revealed retinal fissure closure deficit and altered NCCs migration. These observations suggest that neogenin in NCCs is necessary to prevent PHPV pathogenesis, which is likely due to neogenin's functions in regulating NCC delamination/migration and retinal fissure closure.

Results {#sec2}
=======

PHPV-like pathology in *Neo*^m/m^ mice {#sec3}
--------------------------------------

To investigate neogenin's function in mouse retina, we took advantage of *Neo*^m/m^ mice, a hypomorphic allele with \~ 90% loss of neogenin as described previously ([@ref31]), and examined their eye phenotypes. *Neo*^m/m^ mice die around P28 ([@ref31]). Thus, the whole-mount and histologic investigations of postnatal (P) eyes at ages of P1, P7, P20, and P30 from *Neo^m/m^* and their littermate control (*Neo^+/+^* and *Neo^+/m^*) pups were carried out. Remarkably, a large pigmented mass was identified in all ages of *Neo*^m/m^ eye, which encapsulated vasculature posterior to the lens and extended toward the retina in a funnel-like shape (Figure [1A](#f1){ref-type="fig"} and [B](#f1){ref-type="fig"}), indicative of a pathologic feature of PHPV ([@ref15]; [@ref7]; [@ref68]; [@ref24]). *Neo*^m/m^ eye also exhibited several additional hallmark characteristics of PHPV, including retinal atrophy or smaller eye (microphthalmia; Figure [1A](#f1){ref-type="fig"} and [B](#f1){ref-type="fig"}; [Supplementary Table S1](#sup1){ref-type="supplementary-material"}), catarods (data not shown). These phenotypes were detectable in \~100% of the mutant eyes in all postnatal ages examined.

![*Neo* ^m/m^ mice develop symptoms of PHPV and permanent retrolental cell mass. (**A**) In a retinal whole-mount view (P9, P14, and P20), the retrolental mass located behind the lens and attached to the retina exhibit pigment cell characteristics. Scale bar, 500 μm. (**B**) Histologic sections of *Neo*^+/+^ and *Neo*^m/m^ mice at P1, P7, P14, and P30, the retrolental mass exist in *Neo*^m/m^ vitreous during life time (*Neo*^m/m^ mice only have a lifespan around P30). At P30 the *Neo*^m/m^ eye showed microphthalmia phenotype of which the pigment cell invaded into the inner eye tissues, such as retina. Scale bar, 500 μm.](mjz076f1){#f1}

Normal hyaloid vessel regression in postnatal *Neo*^m/m^ mice {#sec4}
-------------------------------------------------------------

Previous studies have indicated that PHPV may result from a failure regression of the hyaloid vessels ([@ref12]; [@ref43]; [@ref54]). We thus examined hyaloid vessels surrounding lens of *Neo*^+/+^ and *Neo*^m/m^ mice at ages of P1, P7, and P14 by Isolectin B4 staining (Figure [2A](#f2){ref-type="fig"}). *Neo*^m/m^ eyes exhibited slightly more hyaloid vessels than that of *Neo*^+/+^ littermate controls at ages of P1 (Figure [2A](#f2){ref-type="fig"} and [B](#f2){ref-type="fig"}). However, at age of P7 and P14, marked reductions in hyaloid vessels were observed in both *Neo*^+/+^ and *Neo*^m/m^ mice, and no significant difference of hyaloid vessel density was detectable between *Neo*^+/+^ and *Neo*^m/m^ mice (Figure [2A](#f2){ref-type="fig"} and [B](#f2){ref-type="fig"}). At age of P14, the ratio of retrolental mass area over lens area was lower than that observed at P7 (Figure [2C](#f2){ref-type="fig"}). These observations are in line with the view that mouse hyaloid vessels normally regress during the first two weeks of postnatal development ([@ref21]), and suggest that the PHPV-like phenotype in *Neo*^m/m^ may not due to a defective postnatal hyaloid vessel regression, but is likely to be resulted from a defect during embryonic development.

![Hyaloid vessel structures regressed in area outside retrolental mass within *Neo*^m/m^ eye after birth. (**A**) Whole-mount preparation of lenses detected from the posterior of *Neo*^+/+^ and *Neo*^m/m^ eyes at several postnatal stages. Lenses were dissected with hyaloid vessels intact and retrolental mass attached, and stained with fluorescein isothiocyanate (FITC)-conjugated isolectin-B4. The retrolental mass was highlighted by a yellow-dotted line. Scale bar, 500 μm. (**B**) Quantification of vessel density (vessel area vs. posterior lens area) at several postnatal stages in *Neo*^+/+^ and *Neo*^m/m^ eyes. Hyaloid vessel regression was observed both in *Neo*^+/+^ and *Neo*^m/m^ eyes. *n* = 7, \*\**P* \< 0.01. (**C**) Quantification of retrolental mass density (retrolental mass area vs. posterior area) at different postnatal stages.](mjz076f2){#f2}

Retrolental mass in *Neo*^m/m^ embryos with characteristics of neural crest origin {#sec5}
----------------------------------------------------------------------------------

We then investigated embryonic phenotypes in *Neo*^m/m^ mice. As shown in Figure [3A--C](#f3){ref-type="fig"}, hematoxylin and eosin (H&E) staining analysis of *Neo*^+/+^ and *Neo*^m/m^ embryonic sections (E11.5--E14.5) showed slight increases in area of cell mass retrolentally. At E16.5, a marked increase in retrolental cell mass was detected in the mutant eye (Figure [3D](#f3){ref-type="fig"} and [E](#f3){ref-type="fig"}). These results suggest that the retrolental cells may start their regression in *Neo*^+/+^ eye, but not *Neo*^m/m^ eye, after E14.5. The increase in retrolental cell mass in E10.5 mutant eye was not due to increased cell proliferation, as no significant difference in Ki67-positive cells over 4',6-diamidino-2-phenylindole (DAPI)-positive cells was detected between *Neo*^+/+^ and *Neo*^m/m^ eyes at E10.5 (Figure [3F](#f3){ref-type="fig"}). However, Ki67-positive cells were higher in the retrolental mass in E16.5 *Neo*^m/m^ vitreous compared with that in *Neo*^+/+^ eyes (Figure [3G](#f3){ref-type="fig"}), suggesting a possible cellular mechanism for the elevated retrolental cell mass in E16.5 mutant embryos.

![The persistent primary vitreous in the *Neo*^m/m^ mice originated from the beginning of eye cup formation and increased in volume during ocular development. (**A**--**D**) H&E staining of embryonic eye cup in coronal plane at E11.5, E12.5, E14.5, and E16.5. Scale bar, 100 μm. Enlarged scale bar, 25 μm. (**E**) Quantitative analysis of retrolental mass area (μm^2^) in **A**--**D**. *n* = 7, \**P* \< 0.05, \*\*\**P* \< 0.001. Data as mean ± SEM. Student's *t*-test. (**F**) Ki67 immunostaining of *Neo*^+/+^ and *Neo*^m/m^ eye cup at E10.5. Quantification of Ki67-positive cells vs. DAPI-positive cells. No significant difference. *n* = 4. Scale bar,  50 μm. (**G**) Ki67 immunostaining of eye cup at E16.5. Enlarged area indicates the retrolental mass. Quantification of Ki67-positive cells vs. DAPI-positive cells. Significant difference. *n* = 4. Scale bar, 50 μm.](mjz076f3){#f3}

The retrolental vitreous contains elements of the hyaloid vessels, which are composed of endothelial cells and other types of perivascular cells ([@ref21]; [@ref70]; [@ref56]). These cells are believed largely derived from neural crest origin ([@ref2]; [@ref56]). We thus immunostained control and mutant embryos with antibodies against PDGFRβ, CD31, AP2β, and MiTF, markers for pericytes, endothelial cells, NCCs, and melanocyte precursors, respectively. In comparison to E12.5 *Neo*^+/+^ embryos, more PDGFRβ-positive cells (pericytes) were emerged in the vitreous of the *Neo*^m/m^ eye (Figure [4A--C](#f4){ref-type="fig"}). In addition, AP2β^+^ NCCs were higher in the mutant eye (Figure [4A](#f4){ref-type="fig"} and [C](#f4){ref-type="fig"}). We also found abundant CD31-positive cells in the vitreous of *Neo*^+/+^ and *Neo*^m/m^ eye (Figure [4D--F](#f4){ref-type="fig"}), and limited number of NG2-positive cells (for pericytes marker; Figure [4D](#f4){ref-type="fig"} and [F](#f4){ref-type="fig"}) only in *Neo*^m/m^, but not *Neo*^+/+^ eyes (Figure [4D](#f4){ref-type="fig"} and [F](#f4){ref-type="fig"}). Furthermore, there was a greater prevalence of AP2β-positive cells in the vitreous of the *Neo*^m/m^ eye at E12.5 compared to the *Neo*^+/+^ eye (Figure [4A--C](#f4){ref-type="fig"}). MiTF-positive cells were found residing in the vitreous of the *Neo*^m/m^, but not *Neo*^+/+^, eye as early as E14.5 (Figure [4G--I](#f4){ref-type="fig"}). To further identify the origin of the cells in retrolental mass, we used Sox9, FoxD3, and Sox10 antibodies to label migratory NCCs [@ref28]; [@ref40]; ([@ref26]; [@ref60]; [@ref64]). In comparison to E12.5 *Neo*^+/m^ embryos, more Sox9 immuno-positive cells (Sox9^+^) were found inside the *Neo*^m/m^ eyes, and more Sox9^+^ cells outside the eye disc (Figure [4K](#f4){ref-type="fig"} and [L](#f4){ref-type="fig"}), but no significant difference of Sox9^+^ cell ratio (retrolental/outside eye disc) was found between the two groups (Figure [4M](#f4){ref-type="fig"}). As for FoxD3, neither the significant difference of number of FoxD3^+^ cells were found inside and outside the eye discs, nor the ratio (Figure [4J, N, O](#f4){ref-type="fig"} and [P](#f4){ref-type="fig"}). However, abundant Sox10^+^ cells were emerged in the vitreous and fissure of *Neo*^m/m^ eyes rather than the *Neo*^+/m^ groups. No difference of number of Sox10^+^ cells was found outside the eye disc; thus, the Sox10^+^ cell ratio increased in *Neo*^m/m^ group (Figure [4J, Q, R](#f4){ref-type="fig"} and [S](#f4){ref-type="fig"}).

![*Neo* ^m/m^ vitreous contains more pericytes, endothelial cells, melanocyte precursors, and blood cells, and increase of NCCs in E12.5 *Neo*^m/m^ embryos. (**A** and **B**) PDGFRβ (green) and AP2β (red) expressed in the vitreous of *Neo*^+/+^ and *Neo*^m/m^ mice at E12.5. The red-dotted boxes are highlighted as separated figures along the right side. Scale bar, 100 and 10 μm (enlarged). (**C**) Quantification of PDGFRβ (green) and AP2β (red)-positive area vs. DAPI area (%). (**D** and **E**) CD31 (red) and NG2 (green) expressed in the vitreous of *Neo*^+/+^ and *Neo*^m/m^ mice at E12.5. The red-dotted boxes are highlighted as separated figures along the right side. Scale bar, 100 and 10 μm (enlarged). (**F**) Quantification of CD31 (red) and NG2 (green)-positive area vs. DAPI area (%). (**G** and **H**) MiTF-positive cells emerged at E14.5. The red-dotted boxes are highlighted as separated figures along the right side (MiTF, green; CD31 purple). Scale bar, 100 and 10 μm (enlarged). (**I**) Quantification of CD31 and MiTF-positive area vs. DAPI area (%). *n* = 4 eyes, 3 sections each eye, \*\**P* \< 0.01. (**J**) Immunostaining of Sox9 (green), FoxD3 (red) and Sox10 (white) in eyes of E12.5 *Neo*^+/+^ and *Neo*^m/m^ embryos. Scale bar, 100 μm. (**K**--**M**) Quantitative analysis of the Sox9^+^ cells (**K**, Sox9^+^ retrolental cells; **L**, Sox9^+^ cells surrounding eye disc; **M**, the ratio of Sox9^+^ retrolental cells over Sox9^+^ cells surrounding eye disc) in E12.5 *Neo*^+/+^ and *Neo*^m/m^ embryos. (**N**--**P**) Quantitative analysis of the FoxD3^+^ cells (**N**, FoxD3^+^ retrolental cells; **O**, FoxD3^+^ cells surrounding eye disc; **P**, the ratio of FoxD3^+^ retrolental cells over FoxD3^+^ cells surrounding eye disc) in E12.5 *Neo*^+/+^ and *Neo*^m/m^ embryos. (**Q**--**S**) Quantitative analysis of the Sox10^+^ cells (**Q**, Sox10^+^ retrolental cells; **R**, Sox10^+^ cells surrounding eye disc; **S**, the ratio of Sox10^+^ retrolental cells over Sox10^+^ cells surrounding eye disc) in E12.5 *Neo*^+/+^ and *Neo*^m/m^ embryos. *n* = 3 per group. Data are mean ± SEM. Student's *t-*test. \**P*\<0.05, \*\**P*\<0.01, in comparison with control group.](mjz076f4){#f4}

![Co-localization of neogenin at different embryonic stages. (**A**) Coronal sections of E11.5, E15.5, and P9 eye cups in *Neo*^+/+^, *Neo*^+/m^, and *Neo*^m/m^ were co-stained by X-gal and fast red. Scale bar, 100 μm. X-gal staining in coronal and sagittal sections at E15.5. X-gal signals were found expressed in the perioclular mesenchyme, retrolental mass, and lens epithelium. Scale bar, 100 and 25 μm (enlarged). (**B**) Expression of PDGFRβ and Ap2β co-localized with β-gal, which is the puncta shape (white dot) in the vitreous. (**B1**--**B3**) Yellow-dotted areas are highlighted images. Scale bar, 10 μm. (**C**) β-Gal (white) co-labeled with PDGFRβ (green) and Ap2β (red) located in the perinuclear region. AP2β expressed in the nucleus (red) co-labeled with DAPI. In the merged figure, the YZ and XZ axis view show the co-localization of AP2β, PDGFRβ, β-gal, and DAPI. β-gal is located just in the perinuclear region. Scale bar, 2.5 μm. (**C1**) MiTF (green) and CD31 (red) expression co-localized with β-gal, puncta shape (white dot) in the vitreous. Scale bar, 10 μm. (**C2**) β-gal (white) did not co-labeled with CD31 (red). MiTF (green) expressed in the nucleus (red) co-labeled with DAPI but not β-gal (white). In the merged figure, the YZ and XZ axis view shows β-gal co-localized with CD31, but not MiTF. Scale bar, 2.5 μm. (**D**) Quantification of the double immuno-positive cells vs. β-gal^+^ cells in the vitreous of *Neo*^m/m^ eye cup at E13.5 and E14.5. By co-staining we observed β-gal colabeling with 90.5% ± 3.8% of AP2β-positive cells, 17.8% ± 4.9% of CD31-positive cells, 6.5% ± 3.7% of MiTF-positive cells, and 91.7% ± 3.8% of PDGFRβ-positive cells. *n* = 6, \*\**P* \< 0.01. Student's *t*-test.](mjz076f5){#f5}

![*Neo* ^f/f^;*Wnt1*-Cre mice exhibit PHPV phenotype, similar to *Neo*^m/m^ mice. (**A**) Persistent vitreous emergence in the eye of *Neo*^f/f^;*Wnt1*-Cre mice at the P1 stage (H&E staining). Scale bar, 200 μm and 50 μm (enlarged). (**B**) Whole-mount preparation of posterior lens observed in *Neo*^f/f^ and *Neo*^f/f^;*Wnt1-*Cre mice at P1 (IB4 staining, green; DAPI, white). The presence of the retrolental mass is highlighted by the yellow-dotted line. Scale bar, 200 μm. (**C**) Sagittal sections of *Neo*^f/f^ and *Neo*^f/f^;*Wnt1*-Cre eye cup at E12.5 and E14.5 stage. d, dorsal; v, ventral. Scale bar, 100 and 50 μm (enlarged). (**D**) More cells emerged in the vitreous in *Neo*^f/f^;*Wnt1*-Cre eye cup than *Neo*^f/f^ eye cup at E12.5 and E14.5. *n* = 6, \*\**P \<* 0.01. (**E**) Sagittal sections of eye cup showed cells of neural crest origin (Ap2β, red) located in the vitreous in *Neo*^f/f^ and *Neo*^f/f^;*Wnt1-*Cre eye cup at E12.5. Scale bar, 100 μm. (**F**) Quantification of Ap2β-positive cells in the vitreous of *Neo*^f/f^ and *Neo*^f/f^;*Wnt1*-Cre mice. *n* = 6, \*\**P \<* 0.01. (**G**) td labeled cells (NCC origin) emerged in the vitreous, periocular mesenchyme, and neural retina as indicated by serial sagittal sections. *d*, dorsal; *v*, ventral. Scale bar, 100 μm. (**H**) Quantification of Td-positive cells in *Td*^f/f^;*Wnt1*-Cre and *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre mice. *n* = 6. \*\**P \<* 0.01. PM, periocular mesenchyme.](mjz076f6){#f6}

![Greater NCC migration from NC explant in the *Neo*^f/f^;*Wnt1*-Cre mice. (**A**) Representative outgrowth of NCCs in *Neo*^f/f^ and *Neo*^f/f^;*Wnt*1-Cre groups at DIV1 and DIV2 (contrast phase). Yellow-dotted line outlines the edge of the NCC explants. Scale bar, 100 μm. (**B**) Quantification of NCC outgrowth area ratio \[(whole area -- explant area) /explant area\]. Data are presented as rate of outgrowth area vs. original NC explant. \*\**P* \< 0.01, *n* = 6. (**C**) Explant perimeter of *Neo*^f/f^;*Wnt1*-Cre group and *Neo*^f/f^ groups. \*\**P* \< 0.01, *n* = 6. (**D**) AP2β was used as an NCC marker to label NC derived cells with DAPI as a nuclear marker. Scale bar, 100 μm. (**E**) Black and white contrast images were isolated from AP2β immunofluorescence and DAPI-positive signals. Dotted circles were used to measure the migration distance of NCCs from the NC explant. (**F**) Quantification of AP2β-positive cells in different circles (200, 400, 600 μm, and above) that migrated from the NC explant. \*\**P* \< 0.01, *n* = 6. (**G**) Quantification of DAPI-positive cells in different circles. \*\**P* \< 0.01, *n* = 6. Student's *t*-test. (**H**) The terminal migration rate quantification of NCCs at 24 h and 48 h in *Neo*^f/f^ and *Neo*^f/f^;*Wnt*1-Cre groups. \*\**P* \< 0.01, *n* = 10. Student's *t*-test within groups. (**I**) Paradigm of NCC migration through different circles. Circles were drawn around the neural crest explant at 200, 400, and 600 μm surrounding the region of interest. Scale bar, 100 μm.](mjz076f7){#f7}

Expression of neogenin in neural crest-lineage cells {#sec6}
----------------------------------------------------

To understand how neogenin-loss results in PHPV-like phenotype, we examined neogenin's expression pattern in developing eye. In *Neo*^m/m^ mice, a LacZ gene is inserted into the intron of neogenin gene, and thus the LacZ expression/activity is under the control of neogenin promotor ([@ref69]). We thus used this LacZ as a reportor for neogenin's expression. As shown in Figure [5A](#f5){ref-type="fig"}, LacZ activity was undetectable in *Neo*^+/+^ control embryos, but it was obvious in *Neo*^+/m^ and *Neo*^m/m^ retinal sections, demonstrating the specificity. The LacZ signal was weakly detected in \~E11 eye cup (Figure [5A](#f5){ref-type="fig"}), but was strong in \~E13.5 or late stage eye cups of *Neo*^m/m^ embryos (Figure [5A](#f5){ref-type="fig"}). In E15.5 *Neo*^m/m^, LacZ was distributed in neuroretina, lens epithelium, eye stalk, periocular mesenchyme, putative cornea, vitreous, and RPE (Figure [5A](#f5){ref-type="fig"}). In P9 *Neo*^m/m^, LacZ was expressed in the ganglion cell layer, inner nuclear layer, retrolental mass, and RPE (Figure [5A](#f5){ref-type="fig"}). Importantly, LacZ^+^ signals were detectable in the retrolental cell masses in *Neo*^m/m^, but not *Neo*^+/+^ retina, at ages of E15.5 and P9 (Figure [5A](#f5){ref-type="fig"}). We next determined if these LacZ^+^ cells are NCCs or derived from NCCs. Co-immunostaining analysis using antibodies against β-gal with anti-AP2β (a marker for NCCs), anti-PDGFRβ (a marker for pericytes), or anti-MiTF (a marker for melanocyte precursors) revealed co-distribution of LacZ^+^Ap2β^+^ and LacZ^+^PDGFβ^+^ cells (Figure [5B](#f5){ref-type="fig"}), suggesting that neogenin is highly expressed in AP2β^+^ NCCs and NCC derived PDGFβ^+^ pericytes. MiTF^+^LacZ^+^ cell was seldom observed (Figure [5C](#f5){ref-type="fig"} and [C1](#f5){ref-type="fig"}), and few CD31^+^ cells were co-labeled with LacZ (Figure [5C](#f5){ref-type="fig"} and [C2](#f5){ref-type="fig"}), in line with the view for neogenin's expression largely in NCCs (Figure [5D](#f5){ref-type="fig"}).

PHPV-like pathology in NCC neogenin cKO mice, *Neo*^f/f^;*Wnt1*-Cre mice {#sec7}
------------------------------------------------------------------------

We then examined whether loss of neogenin in NCCs contributes to the PHPV-like pathology. To this end, we crossed *Neo*^f/f^ with *Wnt1*-Cre to generate NCC selective neogenin cKO mice, *Neo*^f/f^;*Wnt1*-Cre mice, as *Wnt1*-Cre expresses Cre selectively in NCC lineage cells ([@ref4]; [@ref6]; [@ref59]). Indeed, *Neo*^f/f^;*Wnt1*-Cre, but not control (*Neo*^f/f^) mice, showed pigmented retrolental mass in the vitreous after birth by both H&E and IB4 staining analyses (Figure [6A](#f6){ref-type="fig"} and [B](#f6){ref-type="fig"}). Further examination of their embryos (E12.5 and E14.5) revealed similar phenotypes as that in *Neo*^m/m^ embryos, displaying increased retrolental cell masses (Figure [6C](#f6){ref-type="fig"} and [D](#f6){ref-type="fig"}). Moreover, these retrolental cell masses were positive for AP2β and *Wnt1*-Cre-driven tdTomato, markers for NCCs, indicating their NCC identity (Figure [6E](#f6){ref-type="fig"} and [G](#f6){ref-type="fig"}). As quantified, more AP2β immune-positive cells resided in the vitreous of *Neo*^f/f^;*Wnt1*-Cre mice (Figure [6E](#f6){ref-type="fig"} and [F](#f6){ref-type="fig"}), and more Td-positive cells were found in the vitreous of *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre mice (Figure [6H](#f6){ref-type="fig"}). These results implicate that neogenin in NCCs plays a critical role in NCC delamination/migration/differentiation, and thus preventing PHPV-like deficit.

In addition to *Neo*^f/f^;*Wnt1*-Cre mice, we also crossed *Neo*^f/f^ mice with *GFAP*-Cre and *Nestin*-Cre to generate *Neo*^f/f^;*GFAP*-Cre and *Neo*^f/f^;*Nestin*-Cre, respectively. In both lines, neogenin was knocked out in neural stem cells and astrocytes. In contrast from *Neo*^f/f^;*Wnt1*-Cre mice, both *Neo*^f/f^;*GFAP*-Cre and *Neo*^f/f^;*Nestin*-Cre mutant mice showed no pigmented retrolental masses and no difference in hyaloid vessel density was at ages of P1 and P15 ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), providing additional evidence for neogenin's expression in NCCs, but not in neural stem cells or astrocytes, to be essential for preventing the increased retrolental cell mass.

Increased cell migration in neural crest explant cultures from *Neo*^f/f^;*Wnt1*-Cre embryos {#sec8}
--------------------------------------------------------------------------------------------

To test if neogenin expression in NCCs regulates NCC migration in a cell autonomous manner, we cultured neural crest explants from E9 control (*Neo*^f/f^) and *Neo*^f/f^;*Wnt1-*Cre embryos as described previously ([@ref9]). To exclude variation of neural crest explant size, we measured the outgrowth area over original neural crest explant area according to [@ref45]. A larger NCC migratory area and a greater perimeter of explant were detected in explants from *Neo*^f/f^;*Wnt1*-Cre embryos following 24-h or 48-h cultures (Figure [7A--C](#f7){ref-type="fig"}). Next, we directly measured the terminal dynamics of cell migration by randomly measuring the distance of NCC leading edges from the center of the explants at 24 h and 48 h DIV. A faster migration rate was found in *Neo*^f/f^;*Wnt1-*Cre group than control group (*Neo*^f/f^) in 24-h and 48-h measurement (Figure [7H](#f7){ref-type="fig"}), respectively, which suggested the loss of function of neogenin promotes the NCC migration. The explant cultures were then fixed and immunostained with anti-AP2β to verify the identity of NCCs. Indeed, they were positive for AP2β antibody (Figure [7D](#f7){ref-type="fig"} and [E](#f7){ref-type="fig"}). In addition, more AP2β-positive and DAPI-positive cells were observed in *Neo*^f/f^;*Wnt1*-Cre cultures as compared with that of *Neo*^f/f^ cultures (Figure [7F](#f7){ref-type="fig"} and [G](#f7){ref-type="fig"}), supporting the view for increased cell migration in neogenin KO NCCs (Figure [7I](#f7){ref-type="fig"}).

Delayed retinal fissure closure in both *Neo*^m/m^ and *Neo*^f/f^;*Wnt1*-Cre embryos {#sec9}
------------------------------------------------------------------------------------

During the process of cellar influx and migration into the embryonic eye cup, the neural retinal fissure closes to form intact morphology of the eye ([@ref17]). The distal rim of the optic cup is known as the ciliary marginal zone (CMZ) and plays a vital role in fissure formation ([@ref5]). We thus examined retinal fissure structures. At E11.5, a critical time window for eye cup formation, *Neo*^+/+^ embryos formed an intact retinal fissure along their sagittal plane (Figure [8A](#f8){ref-type="fig"}). However, *Neo*^m/m^ embryos exhibited a deficit in retinal fissure closure (Figure [8A](#f8){ref-type="fig"}), which is concurrent with more retrolental cells emerging in the vitreous (Figure [8B](#f8){ref-type="fig"}). 3D images of eye tissue were used to further assess the fissure deficit ([Supplementary 3D video](#sup1){ref-type="supplementary-material"}). Moreover, AP2β-positive cells were accumulated between the CMZ region and the vitreous at E11.5 ([Supplementary 3D video](#sup1){ref-type="supplementary-material"}), and more AP2β-positive cells emerged in the anterior and posterior eye cup at E12.5 ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Interestingly, the retinal fissure remained open in *Neo*^f/f^;*Wnt1*-Cre at both E11.5 and E12.5 (Figure [8C](#f8){ref-type="fig"}; [Supplementary Table S2](#sup1){ref-type="supplementary-material"}). This deficit was further confirmed by characterizing tdTomator cells in *Neo*^f/f^;*Td*^f/f^;*Wnt1*-Cre and *Td*^f/f^;*Wnt1*-Cre mice (Figure [8D](#f8){ref-type="fig"}). In Ai9 mice, tdTomato was turned on by *Wnt1*-Cre expression. As shown in Figure [8D--F](#f8){ref-type="fig"}, the diameter of the fissure structures, the PDGFRβ, and tomato double positive cells within the eye cup were all increased in *Neo*^f/f^;*Td*^f/f^;*Wnt1*-Cre embryos as compared with those in control (*Td*^f/f^;*Wnt1*-Cre) mice (Figure [8E](#f8){ref-type="fig"} and [F](#f8){ref-type="fig"}). Together, these results suggest that in addition to NCC cell migration, the delayed retinal fissure closure may allow more NCCs migrating into the eye cup, revealing another underlying mechanism for PHPV-like pathology.

Discussion {#sec10}
==========

Although several genetic risk factors have been identified in patients with PHPV ([@ref55]; [@ref47]; [@ref13]; [@ref36]; [@ref63]; [@ref25]; [@ref44]; [@ref56]; [@ref51]), it remains elusive about the molecular and cellular mechanisms underlying the formation of PHPV. Neogenin is a DCC family receptor, implicated in regulating multiple signals induced by various ligands, including netrins, RGMs, BMPs, and sonic hedgehog ([@ref57]; [@ref31]; [@ref69]; [@ref18]; [@ref62]; [@ref41]; [@ref19]). Here, we provide evidence for neogenin's unrecognized function in regulating PHPV. *Neo*^m/m^ mice develop an unregressed retrolental mass, suggesting a negative role of neogenin in PHPV formation. A high level of neogenin expression in embryonic NCC lineage cells and the PHPV-like deficit detected in *Neo*^f/f^;*Wnt1*-Cre mice suggest a crucial role of neogenin in NCC lineage cells in this pathology. Furthermore, neogenin deficiency increases NCC migration in cultured explants and elevates NCC distribution in the retrolental area. Together, these observations lead us to speculate that neogenin deficiency in NCCs may promote PHPV development by increasing NCC migration.

PHPV is defined as a disease resulting from failed regression of the intraocular vasculature ([@ref12]; [@ref22]). During embryonic development, the cells in hyaloid vessels and vitreous are derived from the neural crest and mesoderm ([@ref11]). We have found that the retrolental cell mass in *Neo*^m/m^ embryos consists of pericytes, endothelial cells, pigmented cells, and blood cells that originate from the neural crest and the mesoderm, suggesting that the cells in the *Neo*^m/m^ retrolental mass are similar to those found in *Neo*^+/+^ mice, consistent with a previous report ([@ref56]). Hyaloid regression occurs in the first few weeks of postnatal development in mice ([@ref50]). In *Neo*^m/m^ pups, hyaloid vasculature in the area outside of the hyperplastic mass was decreased over age, but did not regress until P14 (Figure [2A](#f2){ref-type="fig"}). These observations suggest that the retrolental mass in neogenin mutant embryos may not be a direct consequence of failed hyaloid vessel regression, but a potential cause of the observed PHPV phenotype. The latter view is also in line with a previous report ([@ref56]).

How is the primary vitreous cell mass formed? A greater primary vitreous cell mass was detected \~E11 *Neo*^m/m^ eye cups (Figure [3](#f3){ref-type="fig"}; [Supplementary 3D video](#sup1){ref-type="supplementary-material"}), which failed to be regressed at E16.5 (Figure [3](#f3){ref-type="fig"}). These observations, in line with the view for human PHPV to be developed during embryonic stages ([@ref13]), implicate a loss of the restriction of cell migration in developing *Neo*^m/m^ eye. However, these observations cannot eliminate the possibility that increased neural crest progenitors may result in an elevated primary vitreous cell mass. To this end, examining Sox9, FoxD3, and Sox10 early stage NCC markers in control (heterozygotes) and homozygote mutant embryos showed more Sox9^+^ and Sox10^+^ NCC-like cells not only in the mutant retrolental area, but also in the area surrounding the eye discs of \~E12 mutants (Figure [4J](#f4){ref-type="fig"}). These results thus suggest that neogenin mutation may affect not only NCC distribution/migration, but also NCC progenitors. However, using proliferative marker, Ki67, we did not observe increased cell proliferation \~E11 mutant embryos (Figure [3F](#f3){ref-type="fig"}), but detect an increase in Ki67^+^ cells in \~E16.5 mutant retrolental area (Figure [3G](#f3){ref-type="fig"}). These results thus eliminate the possibility for increased NCC progenitors at early stage (e.g. \<E10.5) as a major cause for the elevated retrolental cell mass, but the possibility for increased NCCs or NCC progenitors at later stages (e.g. \>E12) to contribute to the elevated retrolental cell mass remains.

In addition to cell proliferation, several lines of evidence suggest a role of neogenin in regulating NCC migration, which may underlie the increased retrolental mass in neogenin mutant embryos. First, increased retrolental cell mass was detectable as early as \~E11 neogenin mutant embryos, which appears to be largely derived from NCC lineage (Figures [3A](#f3){ref-type="fig"} and [5A](#f5){ref-type="fig"}). Second, neogenin is highly expressed in NCC lineage cells. Third, neogenin cKO in *Wnt1-*Cre^+^ NCCs showed similar PHPV-like deficit as that of *Neo*^m/m^ mutant mice (Figures [6](#f6){ref-type="fig"} and [8](#f8){ref-type="fig"}). Fourth, the NCC containing explant culture experiments showed increased NCC migration rate in neogenin mutant mice, as compared with that of wild-type control mice (Figure [7](#f7){ref-type="fig"}).

It is noteworthy that additional mechanisms may underlie neogenin regulation of PHPV pathogenesis. In addition to the increases in NCC migration and NCC progenitors, the unclosed fissure may allow more neural crest-derived cells migrating into the eye cup. Interestingly, neogenin loss-of-function in *Wnt1*-Cre cells also resulted in an unclosed fissure (Figure [8C](#f8){ref-type="fig"} and [D](#f8){ref-type="fig"}), a similar defect as that of *Neo*^m/m^ embryos. Also of interest to note a report that *Neo*^m/m^ mice show impaired cell adhesions in both ependymal cells and radial glial cells, resulting in a hydrocephalus-like deficit ([@ref42]). Thus, it will be of interest to further investigate how neogenin regulates fissure closure, and whether neogenin regulates this event via its regulation of WAVE complex as described in radial glial cells ([@ref42]).

![Deficit of ocular fissure closure in the *Neo*^m/m^ eye. (**A**) Head of embryo from E11.5 *Neo*^+/+^ and *Neo*^m/m^ mice (phase image). Fissure in *Neo*^+/+^ eye completely closed and made a circle (right side), but the *Neo*^m/m^ eye cannot form a closed fissure. Black dotted line shows morphology of the eye cup (sagittal view). Scale bar, 500 and 200 μm (enlarged). (**B**) Coronal sections of E11.5 *Neo*^+/+^ and *Neo*^m/m^ mice by DIC scanning and H&E staining. More cells emerged in the vitreous of *Neo*^m/m^ mice. Scale bar, 50 μm. (**C**) Lateral profile of *Neo*^f/f^ and *Neo*^f/f^;*Wnt1*-Cre mice at E11.5, E12.5, and E13.5. Scale bar, 500 and 100μm (enlarged). (**D**) Sagittal sections of *Td*^f/f^;*Wnt1*-Cre and *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre eyes co-labeled with PDGFRβ at E11.5. Td (red) labeled cells emerged around the eye cup, into the fissure (open white triangle) and the vitreous (white triangle). Scale bar, 50 μm. (**E**) Larger area of PDGFRβ-positive cells were found in *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre mice. (**F**) Td-positive area was larger in *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre mice than *Td*^f/f^;*Wnt1*-Cre mice. *n* = 6, \*\**P* \< 0.01. Student's *t*-test.](mjz076f8){#f8}

Materials and methods {#sec11}
=====================

Mouse breeding {#sec12}
--------------

*Neo1* Rosa-26 LacZ transgenic mice were kindly provided by Dr Sue Ackerman (The Jackson Laboratory) as previously described ([@ref31]; [@ref69]). *Neogenin*^f/f^ (*Neo*^f/f^) mice were generated by Ozgene. *Wnt1*-Cre, *Nestin*-Cre (donated by Dr Rudiger Klein), *GFAP*-Cre and *Ai9* mice (all C57BL/6 genetic background, from Jackson Laboratory) were used and maintained in line with the protocols approved by Augusta University IACUC committee according to US National Institutes of Health guidelines. The *Ai9* mice (stock number 007909), as previously reported ([@ref33]; [@ref19]), have loxP-flanked STOP cassette preventing transcription of a CAG promoter-driven protein, tdTomato which is expressed following Cre-mediated recombination. Briefly, we first generated *Neo^f/w^*;*X*-Cre. *Neo*^f/w^;*Wnt1*-Cre male mice were then bred with *Neo*^f/f^ female mice to yield 25% *Neo*^f/f^;*Wnt1*-Cre mice and 25% *Neo*^f/f^ mice as littermate controls. These male *Neo*^f/f^;*GFAP*-Cre, *Neo*^f/f^;*Nestin*-Cre mice were obtained by breeding with *Neo*^f/f^ female. *Td*^f/f^;*Neo*^f/f^;*Wnt1*-Cre mice were obtained by breeding *Neo*^f/f^; *Td*^f/f^ mice with *Neo*^f/w^;*Wnt1*-Cre. These mice were confirmed by genotyping using PCR and western blot analysis ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). For embryo generation, embryonic day (E) 0.5 was defined as noon of the day when the vaginal plug was observed.

H&E staining and *β*-gal detection {#sec13}
----------------------------------

H&E staining protocols have been described previously ([@ref32]). Briefly, embryo heads were freshly dissected and sectioned. P0-P30 dissected eyes were prepared in 4% formaldehyde fixation solution at 4°C overnight, dehydrated the following day in 30% sucrose, and embedded in OCT (Sakura). Sections were stained with H&E solution (Sigma-Aldrich), followed by alcohol dehydration and xylene permeability.

β-Gal activity was detected as described previously ([@ref32]). In brief, frozen eye sections derived from *Neo*^+/+^ and *Neo*^m/m^ mice were fixed with 1.5% glutaraldehyde plus 0.5% Paraformaldehyde and incubated with X-gal solution (2 mM MgCl~2~, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 0.1% X-gal) in the dark at 37°C for 30 min. The slides were then washed twice and co-stained with fast red (Vector) and were mounted using permount (Thermo Fisher Scientific). Images were taken by microscope with high sensitivity CCD (AxioCam, Carl Zeiss).

Immuno- and histo-staining {#sec14}
--------------------------

Embryo heads (E10.5--E16.5) were freshly dissected, cryopreserved in OCT compound, and sectioned along the coronal and sagittal plane, followed by 4% formaldehyde fixation solution at 4°C for 1 h. A total of 16--18 μm embryonic tissue sections were then processed for immunostaining by phosphate buffered saline (PBS) rinse, blocked for 1 h in 5% BSA plus 0.1% triton at room temperature (RT), incubated with primary antibodies overnight at 4°C, followed by 1 h incubation at RT with fluorescence-conjugated secondary antibodies (Jackson Laboratory). The slides were mounted using DAPI mounting medium (Vector). The primary antibodies used in the experiments were anti-PH3 (1:500, Millipore), anti-Ki67 (1:400, Millipore), anti-MiTF (1:400, Abcam), anti-AP2β (1:300, Cell Signaling Technology), anti-CD31 (1:500, BD), anti-PDGFRβ (1:500, Abcam), anti-Sox9 (1:300, Millipore), anti-FoxD3 (1:300, Cell Signaling Technology), and anti-Sox10 (1:300, Cell Signaling Technology). Hyaloid vessels and retinal vessels were stained using fluorescein isolectin B4 (1:500, Vector Laboratories) at 4°C overnight. DAPI (Sigma and Vector Laboratories) was used for nuclear staining.

Neural crest explants primary culture {#sec15}
-------------------------------------

E9 embryos were dissected from *Neo*^f/w^;*Wnt1*-Cre pregnant mice in ice cold PBS according to [@ref9]. After removal of the heart tube and the pharyngeal arches, transverse cuts were made just posterior to the optic vesicles, through the diencephalon. Cranial tissue was digested in 2% pancreatin (Sigma) for 15 min at RT, and the digested tissue was plated onto Metrixgel (BD)-coated cover glasses. Cranial NCC explants were cultured at 37°C (5% CO~2~/95% air) for 0--48 h in complete NCC culture medium supplied with hydrocortisone, transferrin, triiodothyronine (T3), glucagon, insulin, epidermal growth factor, and fibroblast growth factor, plus 1% penicillin and streptomycin. Before staining, explants were fixed for 10 min with 4% PFA.

Analysis of NCC migration in vitro {#sec16}
----------------------------------

Cell migration over 2 days was assessed by measuring the percentage of increased area and perimeter as described ([@ref45]), taking into account any variation due to different original size of the neural crest explant. $$\documentclass[12pt]{minimal}
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Migration rate was analyzed by measuring the distance traveled by AP2β-positive cells beyond 200, 400, 600 μm, and above at 24-h and 48-h cultures according to [@ref48] with minor modifications. Briefly, extent of chain and cell outgrowth using a scale that originates from the center of the explant. Random cellular extensions (8 chains in each explant) were quantified and averaged from six independent explants.$$\documentclass[12pt]{minimal}
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Migration rate and distance analysis were made on at least six neural crest explants for each genotype. All areas, perimeter, and distance measurements were performed using Image J software (NIH).

Western blotting {#sec17}
----------------

Brain tissues and eye samples were lyzed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 5 mM sodium fluoride, 2 mM sodium orthovanadate, and protease inhibitor cocktail) for 30 min on ice and centrifuged at 12000 *g* for 20 min. The concentration of protein lysate was determined using a bicinchoninic acid (BCA) protein assay kit (Bio-rad). Proteins were separated by 8%--10% sodium dodecyl sulphate-polyacrylamide gel electrophoresis gel electrophoresis and electro-transferred onto the nitrocellulose membrane and were then blocked in 5% skim milk at RT for 1 h and incubated with primary antibody overnight at 4°C. Membranes were rinsed on the next day, followed by 1 h incubation (RT) with an appropriate horseradish peroxidase-conjugated secondary antibody (1:5000, Thermo). Chemiluminescent detection was performed with the ECL kit (Pierce). Rabbit polyclonal anti-neogenin was generated as described previously ([@ref66]), using the GST-C-terminus of neogenin fusion protein as the antigen. β-Actin (1:10000, Sigma) was detected alongside the experimental samples as a loading control.

Whole-mount hyaloid preparation {#sec18}
-------------------------------

WT and *Neo*^f/f^, *Neo*^f/f^;*GFAP*-Cre, *Neo*^f/f^;*Wnt1*-Cre, *Neo*^f/f^;*Nestin*-Cre eyes were enucleated and their corneas removed from P1, P7, and P15 mice. The dissected eyes were fixed for 2 h in 4% paraformaldehyde on ice, after which the eyes were rinsed in PBS. The retinal cup along with the lenses then was removed from the sclera carefully, after which the retina was dissected apart from the posterior pole with the intact hyaloid vessels attached to the lens. Lenses with the hyaloid network were stained by FITC-conjugated isolectin-B4 mixed with phosphate buffered solution with 0.1% triton (PBST) overnight (1:400, FL-1201; Vector Laboratories) and mounted in DAPI medium (H-1200, Vector Laboratories). Z-stack images were taken using a Zeiss confocal microscope system LSM510. Density of hyaloid vessels was quantified as the ratio (%) of area of hyaloid vessels vs. the posterior lens area by an Angio tool software (NIH/NCI). Quantification of vessels the tunica vasculosa lentis was modified from that have been described previously ([@ref21]). Briefly, an equator of the lens was drawn on the posterior lens, and vessels crossing this line were counted by Angio tool software (below). By confocal scanning, we could obtain all the z-stack layers from the half lens with hyaloid vessels. For immune-labeled cells, 6--8 tissue blocks from3--4 mice (two blocks per mouse) were taken from each group. Immune-positive signals were quantified (2--3 measurements per tissue block, 4--6 animals per group).

Statistical analysis {#sec19}
--------------------

All data presented represent results from at least three independent experiments. Statistical analysis was performed using Student's *t*-test or ANOVA with pair-wise comparisons. Statistical significance was defined as *P* \< 0.05.
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